General Information of This Payload
Payload ID
PAY0TMFSO
Name
Conjugate No.136 Payload
Synonyms
Conjugate No.136 Payload
   Click to Show/Hide
Structure
Formula
C44H42N8O9
Isosmiles
C=C(CN1C(C2=CC(OC)=C(OCCCC(NC3=CN(C)C(C(NC4=CC=C(C5=CN(C)C(C(N6C=CC7=CC(C(O)=O)=CC=C76)=O)=C5)C=C4)=O)=N3)=O)C=C2N8)=O)C[C@@]1([H])[C@@H]8O
InChI
InChI=1S/C44H42N8O9/c1-24-16-33-40(54)46-31-20-36(35(60-4)19-30(31)42(56)52(33)21-24)61-15-5-6-38(53)47-37-23-50(3)39(48-37)41(55)45-29-10-7-25(8-11-29)28-18-34(49(2)22-28)43(57)51-14-13-26-17-27(44(58)59)9-12-32(26)51/h7-14,17-20,22-23,33,40,46,54H,1,5-6,15-16,21H2,2-4H3,(H,45,55)(H,47,53)(H,58,59)/t33-,40-/m0/s1
InChIKey
AKSMKCHGMZTFPW-QQLMSYFVSA-N
Pharmaceutical Properties
Molecule Weight
826.867
Polar area
211.28
Complexity
2749.098654
xlogp Value
5.3402
Heavy Count
61
Rot Bonds
12
Hbond acc
13
Hbond Donor
5
Each Antibody-drug Conjugate Related to This Payload
Full Information of The Activity Data of The ADC(s) Related to This Payload
WO2019126691A1 Conjugate No.136 [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 2 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
0.16 nM
Positive HER2 expression (HER2+++/++)
Method Description
OVCAR3 cells were plated at a density of 5000 cells per well and the next day were treated with antibody-PBD conjugate for 3 days.
In Vitro Model High grade ovarian serous adenocarcinoma OVCAR3 cells CVCL_0465
Experiment 2 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50) > 100 nM Moderate HER2 expression (HER2++)
Method Description
JIMT1 cells were plated at a density of 5000 cells per well and the next day were treated with antibody-PBD conjugate for 3 days.
In Vitro Model Breast ductal carcinoma JIMT1 cells CVCL_2077
References
Ref 1 Pyrrolobenzodiazepine antibody conjugates